SEC Form 4/A · accession 0001387131-18-000940
Corindus Vascular Robotics, Inc. · CVRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Louis A Cannon
Director
Period of report
Dec 15, 2017
Accepted (ET)
Mar 6, 2018 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 15, 2017 | A | 9,174 | $0.00 | A | 59,975 | D | |
| Common StockF3,F2 | Dec 15, 2017 | A | 2,293 | $0.00 | A | 62,268 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock represents shares issuable upon vesting of restricted stock units granted as part of the director's annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The remaining quarterly installments will vest on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date.
- F250,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly.
- F3The common stock was issued pursuant to the Director Compensation Policy in lieu of the reporting person's quarterly retainer and meeting fees of $2,500.